Invasive Breast Carcinoma Not Yet Recruiting Phase 1 Trials for Anastrozole (DB01217)

Also known as: Invasive carcinoma of breast / Breast cancer invasive NOS

IndicationStatusPhase
DBCOND0031787 (Invasive Breast Carcinoma)Not Yet Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03554044Talimogene Laherparepvec With Paclitaxel or Endocrine Therapy in Treating Participants With Metastatic, Unresectable, or Recurrent HER2- Negative Breast CancerTreatment